Health Sciences Gr Stock Z Score
Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Health Sciences Gr. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
Health |
Health Sciences Gr Company Z Score Analysis
Health Sciences' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Health Sciences Z Score | -61.4 |
Most of Health Sciences' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Health Sciences Gr is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
Competition |
According to the company's disclosures, Health Sciences Gr has a Z Score of -61.4. This is 1009.63% lower than that of the Food & Staples Retailing sector and notably lower than that of the Consumer Staples industry. The z score for all United States stocks is notably higher than that of the company.
Health Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Health Sciences' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Health Sciences could also be used in its relative valuation, which is a method of valuing Health Sciences by comparing valuation metrics of similar companies.Health Sciences is currently under evaluation in z score category among related companies.
Health Fundamentals
Return On Asset | -0.73 | |||
Operating Margin | (73.91) % | |||
Current Valuation | 39.41 K | |||
Price To Sales | 0 X | |||
Revenue | 358.43 K | |||
Gross Profit | 22.91 K | |||
EBITDA | (4.51 M) | |||
Net Income | (54.49 K) | |||
Cash And Equivalents | 1.71 K | |||
Total Debt | 407 K | |||
Current Ratio | 0.01 X | |||
Book Value Per Share | (0.11) X | |||
Cash Flow From Operations | 38.99 K | |||
Earnings Per Share | (0.13) X | |||
Beta | -28.36 | |||
Market Capitalization | 281 | |||
Total Asset | 1.03 M | |||
Retained Earnings | (32.46 M) | |||
Working Capital | (5.04 M) | |||
Current Asset | 67 K | |||
Current Liabilities | 5.11 M | |||
Z Score | -61.4 | |||
Annual Yield | 0.05 % | |||
Net Asset | 1.03 M |
About Health Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Health Sciences Gr's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Health Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Health Sciences Gr based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Health Sciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Health Sciences' short interest history, or implied volatility extrapolated from Health Sciences options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Health Sciences Gr. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Health Pink Sheet analysis
When running Health Sciences' price analysis, check to measure Health Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Sciences is operating at the current time. Most of Health Sciences' value examination focuses on studying past and present price action to predict the probability of Health Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Sciences' price. Additionally, you may evaluate how the addition of Health Sciences to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |